New-Onset Fulminant Type 1 Diabetes After SARS-CoV-2 Infection
Diabetes Care
.
2023 Aug 1;46(8):e140-e142.
doi: 10.2337/dc23-0536.
Authors
Yunfei Pan
1
,
Xiaojing Zhong
2
,
Wei Qiu
2
,
Feimin Zhao
1
,
Jianping Yao
2
Affiliations
1
Department of General Medicine, Huzhou Central Hospital, Affiliated Central Hospital of Huzhou University, Huzhou, China.
2
Department of Endocrinology, Huzhou Central Hospital, Affiliated Central Hospital of Huzhou University, Huzhou, China.
PMID:
37308094
PMCID:
PMC10369121
DOI:
10.2337/dc23-0536
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Letter
MeSH terms
COVID-19*
Diabetes Mellitus, Type 1* / complications
Humans
SARS-CoV-2